A doxycycline inducible, adenoviral bone morphogenetic protein‐2 gene delivery system to bone
暂无分享,去创建一个
R. Müller | M. Alini | D. Eglin | G. Daculsi | M. Anton | M. Stoddart | S. Zeiter | V. Stadelmann | J. Bara | D. Nehrbass | Iska Dresing | D. C. Betts
[1] Ex vivo , 2020, Definitions.
[2] A. Nowacki,et al. Adverse Events With the Use of rhBMP-2 in Thoracolumbar and Lumbar Spine Fusions: A 9-Year Institutional Analysis , 2015, Journal of spinal disorders & techniques.
[3] D. Rowe,et al. The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur , 2015, Gene Therapy.
[4] M. Elsalanty,et al. Mesenchymal stem cell expression of stromal cell‐derived factor‐1β augments bone formation in a model of local regenerative therapy , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[5] Georg N Duda,et al. T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion. , 2014, Bone.
[6] B. Hallgrímsson,et al. Stem Cell–Derived Endochondral Cartilage Stimulates Bone Healing by Tissue Transformation , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] Mauro Alini,et al. A Standardized Critical Size Defect Model in Normal and Osteoporotic Rats to Evaluate Bone Tissue Engineered Constructs , 2014, BioMed research international.
[8] J. Buchowski,et al. High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases. , 2013, The Journal of bone and joint surgery. American volume.
[9] J. Klein-Nulend,et al. Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro. , 2013, Tissue engineering. Part A.
[10] C. Archer,et al. Enhanced Adenovirus Transduction of hMSCs Using 3D Hydrogel Cell Carriers , 2013, Molecular Biotechnology.
[11] Ivan Martin,et al. Intraoperative engineering of osteogenic grafts combining freshly harvested, human adipose-derived cells and physiological doses of bone morphogenetic protein-2. , 2012, European cells & materials.
[12] S Miettinen,et al. Osteogenic medium is superior to growth factors in differentiation of human adipose stem cells towards bone-forming cells in 3D culture. , 2012, European cells & materials.
[13] C. Evans,et al. Gene delivery to bone. , 2012, Advanced drug delivery reviews.
[14] S. Hodges,et al. Retrospective study of posterior cervical fusions with rhBMP-2. , 2012, Orthopedics.
[15] B. Gansbacher,et al. Optimizing Adenoviral Transduction of Endothelial Cells under Flow Conditions , 2012, Pharmaceutical Research.
[16] P. Knaus,et al. BMPs are mediators in tissue crosstalk of the regenerating musculoskeletal system , 2012, Cell and Tissue Research.
[17] Bradley K Weiner,et al. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.
[18] Huipin Yuan,et al. Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. , 2011, European cells & materials.
[19] Xinping Zhang,et al. Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. , 2011, Bone.
[20] C. Colnot,et al. Trauma-Induced Inflammation and Fracture Healing , 2010, Journal of orthopaedic trauma.
[21] G. Duda,et al. The early fracture hematoma and its potential role in fracture healing. , 2010, Tissue engineering. Part B, Reviews.
[22] Ivan Martin,et al. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering , 2010, Proceedings of the National Academy of Sciences.
[23] G. Daculsi,et al. Biofunctionality of MBCP ceramic granules (TricOs™) plus fibrin sealant (Tisseel®) versus MBCP ceramic granules as a filler of large periprosthetic bone defects: an investigative ovine study , 2010, Journal of materials science. Materials in medicine.
[24] Janka Mátrai,et al. Recent advances in lentiviral vector development and applications. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] T. Einhorn,et al. Bone morphogenetic proteins in orthopaedic surgery. , 2009, Cytokine & growth factor reviews.
[26] G. Daculsi,et al. Comparison of two bone substitute biomaterials consisting of a mixture of fibrin sealant (Tisseel) and MBCP (TricOs) with an autograft in sinus lift surgery in sheep. , 2009, Clinical oral implants research.
[27] E. Schwarz,et al. Biological activation of bone‐related biomaterials by recombinant adeno‐associated virus vector , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[28] H. Iwata,et al. Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study , 2009, International Orthopaedics.
[29] A. Pandit,et al. Fibrin scaffold promotes adenoviral gene transfer and controlled vector delivery. , 2009, Journal of biomedical materials research. Part A.
[30] E. Schwarz,et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.
[31] John R. Johnson,et al. RhBMP-2 Versus Iliac Crest Bone Graft for Lumbar Spine Fusion in Patients Over 60 Years of Age: A Cost-Utility Study , 2009, Spine.
[32] J. Jukes,et al. Endochondral bone tissue engineering using embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.
[33] G. Daculsi,et al. Bone tissue formation in sheep muscles induced by a biphasic calcium phosphate ceramic and fibrin glue composite , 2008, Journal of materials science. Materials in medicine.
[34] G. Daculsi,et al. The safety and efficacy of an injectable bone substitute in dental sockets demonstrated in a human clinical trial. , 2007, Biomaterials.
[35] P H Krebsbach,et al. Localized viral vector delivery to enhance in situ regenerative gene therapy , 2007, Gene Therapy.
[36] Maurilio Marcacci,et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. , 2007, Tissue engineering.
[37] A. Montag,et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[38] J. Reynolds,et al. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. , 2007, The spine journal : official journal of the North American Spine Society.
[39] I. Stratford,et al. Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model. , 2007, Journal of biomolecular techniques : JBT.
[40] W. Hsu,et al. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. , 2007, Bone.
[41] D. Niederwieser,et al. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. , 2006, International journal of molecular medicine.
[42] E Schneider,et al. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. , 2006, Human gene therapy.
[43] M. Bouxsein,et al. Direct percutaneous gene delivery to enhance healing of segmental bone defects. , 2006, The Journal of bone and joint surgery. American volume.
[44] J. Lieberman,et al. Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein. , 2005, The Journal of bone and joint surgery. American volume.
[45] V. Goldberg,et al. FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cells , 2005, Journal of cellular physiology.
[46] J. Fiorellini,et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. , 2005, Journal of periodontology.
[47] F. Jegoux,et al. In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant , 2005, Archives of Orthopaedic and Trauma Surgery.
[48] Hiromu Ito,et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy , 2005, Nature Medicine.
[49] C. Kawcak,et al. Evaluation of Ad‐BMP‐2 for enhancing fracture healing in an infected defect fracture rabbit model , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[50] Rodolfo Quarto,et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. , 2003, Experimental cell research.
[51] Huipin Yuan,et al. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats , 2002, Journal of materials science. Materials in medicine.
[52] L. Muul,et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. Papapoulos,et al. Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A. , 2002, Endocrinology.
[54] Thomas A Einhorn,et al. Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] T A Einhorn,et al. Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[56] R. Müller,et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[57] P Rüegsegger,et al. Introduction and evaluation of a gray-value voxel conversion technique. , 2001, Journal of biomechanics.
[58] R Cancedda,et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. , 2001, The New England journal of medicine.
[59] P. Robbins,et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene , 2000, Gene Therapy.
[60] P. Robbins,et al. Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases. , 1999, Acta orthopaedica Scandinavica.
[61] M. Stemerman,et al. Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[62] K. Kusumoto,et al. Prefabricated muscle flap including bone induced by recombinant human bone morphogenetic protein-2: an experimental study of ectopic osteoinduction in a rat latissimus dorsi muscle flap. , 1998, British journal of plastic surgery.
[63] K. Kusumoto,et al. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. , 1998, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[64] T. Yoneda,et al. Smad5 and DPC4 Are Key Molecules in Mediating BMP-2-induced Osteoblastic Differentiation of the Pluripotent Mesenchymal Precursor Cell Line C2C12* , 1998, The Journal of Biological Chemistry.
[65] I. Martin,et al. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. , 1997, Endocrinology.
[66] W. Tong,et al. Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals. , 1996, Biomaterials.
[67] M. Gossen,et al. Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.
[68] A. Reddi,et al. Initiation and promotion of bone differentiation by bone morphogenetic proteins , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[69] U. Ripamonti. The induction of bone in osteogenic composites of bone matrix and porous hydroxyapatite replicas: an experimental study on the baboon (Papio ursinus). , 1991, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[70] A. Reddi,et al. Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[71] H. Burchardt. Biology of bone transplantation. , 1987, The Orthopedic clinics of North America.
[72] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[73] C. Aring,et al. A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.
[74] P. Hernigou,et al. Cellular therapies for the treatment of non-union: the past, present and future. , 2013, Injury.
[75] M. Marcacci,et al. Bone regeneration with mesenchymal stem cells. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
[76] P. Raab,et al. Biphasic bone substitute and fibrin sealant for treatment of benign bone tumours and tumour-like lesions , 2011, International Orthopaedics.
[77] Ashok K. Goel,et al. Percutaneous bone marrow grafting for the treatment of tibial non-union. , 2005, Injury.
[78] J. Thiery,et al. Fibroblast growth factor-2. , 2000, The international journal of biochemistry & cell biology.
[79] H. Yamasaki,et al. Osteogenic response to porous hydroxyapatite ceramics under the skin of dogs. , 1992, Biomaterials.